# Kyntra Bio, Inc.: Form 8-K, filed Aug 31, 2026

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2026-08-31
- Accepted by EDGAR: Aug 31, 2026, 21:18 ET
- Period: 2026-08-31
- Accession: 0001193125-26-377059
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000119312526377059/kynb-20260831.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000119312526377059/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000119312526377059/kynb-20260831.htm

Filed Aug 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-377059. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.
